Nan Pharma Private Limited
About Nan Pharma Private Limited
Data last updated:
Nan Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2010PTC069300. Its GSTIN is 37AADCN5645A1ZO (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Appala Narasimha Murthy Nukala and Sundari Anupindi.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Door No.43 – 9 – 163 S Towers T S N Colony Dondaparthy, Visakhapatnam, Andhra Pradesh, India – 530016.
As per the financials filed for FY 2022, the company reported a revenue of ₹29.52 Lakh, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹71,400 (net margin 2.4%) and EBITDA of ₹77,413 (EBITDA margin 2.6%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 7% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressDoor No.43 – 9 – 163 S Towers T S N Colony Dondaparthy, Visakhapatnam, Andhra Pradesh, India – 530016
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nan Pharma Private Limited
The main business activity of Nan Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Nan Pharma Private Limited
Nan Pharma Private Limited is audited by RAGHAVENDRA RAM & CO LLP for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAGHAVENDRA RAM & CO LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nan Pharma Private Limited
Nan Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Appala Narasimha Murthy Nukala Also directs: Apoorva Health Services Private Limited | Director | 05 Jul 2010 | 16 Years 3 Months | Current |
| Sundari Anupindi | Director | 05 Jul 2010 | 16 Years 3 Months | Current |
| Surya Venkata Satya Ganti Girija | Director | 16 Jun 2014 | 12 Years 3 Months | Current |
Financials of Nan Pharma Private Limited FY 2022 filings available
Nan Pharma Private Limited reported revenue of ₹29.52 Lakh (down 1% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Nan Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 1% fall in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nan Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹77,413 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹71,400 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nan Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nan Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nan Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nan Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Sep 2012 | The Karnataka Bank Limited | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Nan Pharma Private Limited
Employment history and EPFO contributions of people linked to Nan Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Nan Pharma Private Limited
Nan Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AADCN5645A1ZO | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Nan Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nan Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nan Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nan Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Nan Pharma Private Limited
Frequently Asked Questions about Nan Pharma Private Limited
Nan Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 July 2010 (16+ years old) and is registered under CIN U24232AP2010PTC069300.
Nan Pharma reported revenue of ₹29.52 Lakh for FY 2022 (down 1% YoY).
Nan Pharma has 3 current directors:
- Appala Narasimha Murthy Nukala - Director
- Sundari Anupindi - Director
- Surya Venkata Satya Ganti Girija - Director
Nan Pharma reported a net profit of ₹71,400 (net margin 2.4%) and EBITDA of ₹77,413 (EBITDA margin 2.6%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nan Pharma is -7% over three years and -7% over five years. In the latest year (FY 2022) revenue fell 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nan Pharma is 37AADCN5645A1ZO, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Nan Pharma is U24232AP2010PTC069300. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nan Pharma was incorporated on 05 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Vijayawada.
The registered office of Nan Pharma is at Door No.43 – 9 – 163 S Towers T S N Colony Dondaparthy, Visakhapatnam, Andhra Pradesh, India – 530016.